Atlas Trials

A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)

Clinical trial NCT00336713 · COMPLETED

Trial details

NCT number
NCT00336713
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Depressive Disorder
Start date
2006-05-01
Primary completion
2008-04-01
Enrollment
430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.